Wird geladen...

NEOADJUVANT LENVATINIB IN ADVANCED UNRESECTABLE MEDULLARY THYROID CARCINOMA: A CASE REPORT

OBJECTIVE: Medullary thyroid carcinoma, a rare form of thyroid cancer, is typically managed with surgical excision. However, in patients with locally-invasive tumors, an aggressive surgical attempt may result in unnecessary morbidity. Neoadjuvant tyrosine kinase inhibition has been utilized to downs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AACE Clin Case Rep
Hauptverfasser: Golingan, Hubert, Hunis, Brian, Golding, Allan C., Bimston, David N., Harrell, R. Mack
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Association of Clinical Endocrinologists 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282158/
https://ncbi.nlm.nih.gov/pubmed/32524015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0365
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!